Editorial: New strategies in treatment of differentiated thyroid carcinoma

Jose Federico Carrillo; Carlos Suarez; Alvaro Sanabria; T Metin Onerci; Dhairyasheel Savant

doi:10.3389/fendo.2022.1004734

Editorial: New strategies in treatment of differentiated thyroid carcinoma

Front Endocrinol (Lausanne). 2022 Aug 24:13:1004734. doi: 10.3389/fendo.2022.1004734. eCollection 2022.

Authors

Jose Federico Carrillo¹, Carlos Suarez², Alvaro Sanabria³, T Metin Onerci⁴, Dhairyasheel Savant⁵

Affiliations

¹ Head and Neck Department, National Institute of Cancerology (INCAN), Mexico City, Mexico.
² Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Oviedo, Spain.
³ Departamento de Cirugía, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
⁴ Faculty of Medicine, Hacettepe University, Ankara, Turkey.
⁵ Head and Neck Department, Asian Cancer Institute (ACI), Mumbai, India.

No abstract available

Keywords: Thyroid carcinoma; radionuclide I 131; thyroid cancer biomarkers; thyroid cancer diagnosis; thyroid cancer radiotherapy; thyroid cancer surgery; thyroid cancer targeted therapy; treatment strategies in thyroid cancer.

Publication types

Editorial

MeSH terms

Adenocarcinoma, Follicular* / pathology
Humans
Thyroid Neoplasms* / pathology
Thyroid Neoplasms* / therapy